Avid Bioservices Inc (CDMO)

[hutschi]

Verified November 2017 by Novartis ( Novartis Pharmaceuticals )

They have PS on the table!


Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS


Drug: MBG453
MBG453 is a high-affinity, humanized anti-TIM-3 IgG4 monoclonal antibody which blocks the binding of TIM-3 to phosphatidylserine (PtdSer).

https://clinicaltrials.gov/ct2/show/NCT03066648